In vivo studies, passive immunization against IFNγ and TNF-α of tumor-bearing rats allowed the intake of food, weight preservation, longer life, and better tolerance of larger tumors than in rats receiving a control antibody. The gene discussed is TNF; the disease is neoplasm.